Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
J Dermatol ; 43(3): 321-4, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26362011

RESUMEN

Toxic epidermal necrolysis (TEN) is an adverse reaction that can be induced by various drugs; the associated mortality rate is 20-25%. A previous report showed a weak association between TEN and acetaminophen. Recently, the US Food and Drug Administration declared that acetaminophen is associated with a risk of serious skin reactions, including TEN. Here, we describe the case of a 43-year-old Japanese woman with TEN caused by acetaminophen. She had poorly controlled ulcerative colitis and was treated with high doses of prednisolone, infliximab, acetaminophen and lansoprazole. Nine days after administrating acetaminophen, targetoid erythematous and bullous lesions appeared on the patient's trunk, palms and the soles of her feet. The skin lesions expanded rapidly; within 3 weeks, skin detachment was detected across nearly 100% of the patient's body. However, no mucosal involvement of the eyes, oral cavity or genitalia was found. We performed lymphocyte transformation tests using various drugs; however, a high stimulation index was obtained only with acetaminophen. The patient recovered following treatment with plasmapheresis, i.v. immunoglobulin therapy, topical medication and supportive therapy. Acetaminophen is included in many prescription and over-the-counter products; thus, clinicians should monitor their patients for severe drug reactions, including TEN.


Asunto(s)
Acetaminofén/efectos adversos , Síndrome de Stevens-Johnson/etiología , Síndrome de Stevens-Johnson/patología , Adulto , Colitis Ulcerosa/tratamiento farmacológico , Femenino , Humanos , Prednisolona/administración & dosificación , Síndrome de Stevens-Johnson/tratamiento farmacológico
5.
J Dermatol ; 39(10): 838-42, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22486269

RESUMEN

Effector memory T (T(EM)) cells are a subpopulation of memory T cells that express receptors mediating migration to inflamed tissues and produce various cytokines. Effector memory T-helper (Th)17 (Th17(EM)) cells are thought to be essential for inflammation in Th17-mediated diseases, but have not been studied in detail. To identify superior surface markers to isolate a homogeneous population of Th17(EM) cells from peripheral blood, CD4(+) T cells were isolated from the peripheral blood of healthy donors based on the expression of CCR7, CCR6 and CD146 using six-color flow cytometry. After 4days of culture in the presence of anti-CD3/28 beads, intracellular cytokines were determined by flow cytometric analysis. To investigate the relevance of Th17(EM) cells in Th17-mediated disease, the frequencies of T(EM) -cell subsets in psoriasis were quantified using six-color flow cytometry. An enzyme-linked immunosorbent assay was performed to confirm the interleukin (IL)-17-producing capacity of T(EM) -cell subsets from the peripheral blood of a patient with psoriasis. CCR6(+) CD146(+) T(EM) (CD4(+) CD45RA(-) CCR7(-)) cells had a greater capacity to produce IL-17 than CCR6(+) CD146(-) or CCR6(-) CD146(+) T(EM) cells. Although the percentage of CCR6(+) CD146(+) cells in T(EM) cells was not significantly different between patients with psoriasis and controls, three of eight patients had a higher percentage of CCR6(+) CD146(+) T(EM) cells than the mean +5 standard deviations of the controls. Coexpression of CCR6 and CD146 is a useful marker for Th17(EM) cells. Increasing the number of CCR6(+) CD146(+) Th17(EM) cells in peripheral blood may facilitate estimation of systemic Th17-cell activity in Th17-mediated diseases.


Asunto(s)
Memoria Inmunológica/inmunología , Psoriasis/inmunología , Receptores CCR6/biosíntesis , Células Th17/inmunología , Anciano , Biomarcadores , Antígeno CD146/análisis , Antígeno CD146/biosíntesis , Antígeno CD146/inmunología , Antígenos CD28/inmunología , Complejo CD3/inmunología , Células Cultivadas , Citocinas/biosíntesis , Citocinas/inmunología , Ensayo de Inmunoadsorción Enzimática , Femenino , Citometría de Flujo , Humanos , Interleucina-17/biosíntesis , Masculino , Persona de Mediana Edad , Receptores CCR6/análisis , Receptores CCR6/inmunología , Receptores CCR7/análisis , Receptores CCR7/inmunología , Índice de Severidad de la Enfermedad , Células Th17/química
6.
Acta Derm Venereol ; 92(1): 54-6, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21879241

RESUMEN

Merkel cell carcinoma (MCC), an aggressive skin cancer with neuroendocrine features, has been found to be associated with a new type of human polyomavirus called Merkel cell polyomavirus (MCV). Patients diagnosed with MCC have a significantly increased risk of a second primary cancer. We report here the first case of two primary MCCs arising on the face at different times, associated with MCV infection. The tumour on the patient's right cheek was surgically removed, followed by chemoradiation. After a 10-year tumour-free period, a new tumour developed on the patient's left cheek. Histological and immunohistochemical findings were consistent with MCC. The tumours had high MCV copy numbers and expressed large T antigen, which may play a major role in MCV-mediated carcinogenesis. This case highlights the close links between MCC and MCV.


Asunto(s)
Carcinoma de Células de Merkel/virología , Mejilla , Neoplasias Faciales/virología , Poliomavirus de Células de Merkel/aislamiento & purificación , Neoplasias Primarias Secundarias/virología , Neoplasias Cutáneas/virología , Anciano , Carcinoma de Células de Merkel/patología , Carcinoma de Células de Merkel/terapia , Mejilla/patología , Neoplasias Faciales/patología , Neoplasias Faciales/terapia , Femenino , Humanos , Neoplasias Primarias Secundarias/patología , Neoplasias Primarias Secundarias/terapia , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA